Cellbricks Therapeutics
Latest round
- Seed
Last raised
- Mar 2026
Total raised
- $8.1M
Investors
- 3
About Cellbricks Therapeutics
Founded in 2016 and headquartered in Berlin, Germany, Cellbricks Therapeutics specializes in advanced biofabrication of human tissues.00 mn.Cellbricks Therapeutics specializes in the development of advanced, cell-based human tissue therapeutics aimed at addressing conditions linked to tissue dysfunction. Their flagship products utilize a proprietary light-based biofabrication system, which combines human cells with custom biomaterials to produce biofabricated tissues at scale. This innovative approach seeks to restore lost tissue and organ function for patients suffering from various diseases, with a particular focus on soft tissue defects and organ functionality. The company’s solutions have been validated in vivo, ensuring functionality, scalability, and compatibility with the human immune system.Cellbricks Therapeutics generates revenue through partnerships with healthcare providers and research institutions, facilitating the sale of its human tissue therapeutics. The company structures transactions on a B2B model, with clients purchasing its biofabricated tissue products for use in clinical applications and research settings. These transactions are based on negotiated agreements that detail quantities, pricing, and service terms. While specific pricing for individual products has not been disclosed, the revenue model encompasses direct sales of therapeutic products alongside potential collaborations for research and development projects.Cellbricks Therapeutics is focused on expanding its product line with new tissue therapies targeting a range of conditions, expected to launch within the next two years. The firm plans to penetrate additional markets in North America and Asia by 2025, capitalizing on the growing demand for regenerative medicine solutions.00 mn will support these initiatives, including scaling production capabilities and investing in research and development to enhance their product offerings.
Who invested in Cellbricks Therapeutics
3 investors across 1 round
See all investors in Cellbricks Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 25, 2026
Amount
$8.1M
Investors
Questions about Cellbricks Therapeutics
Who invested in Cellbricks Therapeutics?
Cellbricks Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cellbricks Therapeutics raised?
Cellbricks Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cellbricks Therapeutics last raise money?
Cellbricks Therapeutics's most recent round on record is a Seed, in Mar 2026.
What does Cellbricks Therapeutics do?
Founded in 2016 and headquartered in Berlin, Germany, Cellbricks Therapeutics specializes in advanced biofabrication of human tissues.
Where is Cellbricks Therapeutics headquartered?
Cellbricks Therapeutics is headquartered in Berlin, Germany.
Which VCs invest in companies like Cellbricks Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Cellbricks Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Cellbricks Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.